![Ellen Lubman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ellen Lubman
Direttore/Membro del Consiglio presso
GeneCentric Therapeutics, Inc.
Profilo
Ellen A. Lubman is currently Director at GeneCentric Therapeutics, Inc., Director at Gilda's Club New York City, Inc., Director at Intrepida Bio, Inc., and Independent Director at Reunion Neuroscience, Inc. since 2021.
Former roles include Director at Field Trip Health Ltd., Vice President-External Science & Innovation at Forest Laboratories, Inc. and Actavis, Inc. in 2014, Chief Business Officer at IPI Legacy Liquidation Co. from 2018 to 2020, Principal at Celtic Pharma Management LP, and Chief Business Officer at Werewolf Therapeutics, Inc. Education includes undergraduate studies at Stanford University and an MBA from Stanford Graduate School of Business.
Posizioni attive di Ellen Lubman
| Società | Posizione | Inizio |
|---|---|---|
GeneCentric Therapeutics, Inc.
 GeneCentric Therapeutics, Inc. BiotechnologyHealth Technology Operates as an oncology company transforming cancer diagnostics and genomic profiling through the power of gene expression | Direttore/Membro del Consiglio | - |
Gilda's Club New York City, Inc.
 Gilda's Club New York City, Inc. Miscellaneous Commercial ServicesCommercial Services Provides support services to cancer patients | Direttore/Membro del Consiglio | - |
Intrepida Bio, Inc.
 Intrepida Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines that modulates innate immune system to fight cancer | Direttore/Membro del Consiglio | - |
Reunion Neuroscience, Inc.
 Reunion Neuroscience, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops FDA-approved serotonergic psychedelic therapeutic solutions for underserved mental health disorders | Direttore/Membro del Consiglio | 01/06/2021 |
Precedenti posizioni note di Ellen Lubman
| Società | Posizione | Fine |
|---|---|---|
| IPI LEGACY LIQUIDATION CO | Corporate Officer/Principal | 01/07/2020 |
| FOREST LABORATORIES, INC. | Corporate Officer/Principal | 01/07/2014 |
Celtic Pharma Management LP
 Celtic Pharma Management LP Investment ManagersFinance Celtic Pharma invests in life sciences companies located in Bermuda. The firm targets companies operating in the fields of biotechnology, pharmaceuticals and biological drugs. It provides financing for later stage companies and also takes controlling interest. | Corporate Officer/Principal | 01/11/2008 |
| REUNION NEUROSCIENCE | Direttore/Membro del Consiglio | - |
| WEREWOLF THERAPEUTICS, INC. | Contatto Relazioni con gli Investitori | - |
Formazione di Ellen Lubman
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
63
Relazioni di 1° grado
11
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Forest Laboratories, Inc.
 Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells drug products | Health Technology |
Impel Pharmaceuticals, Inc.
 Impel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late-stage biopharmaceutical company focused on developing transformative therapies for central nervous system disorders | Health Technology |
GeneCentric Therapeutics, Inc.
GeneCentric Therapeutics, Inc. BiotechnologyHealth Technology Operates as an oncology company transforming cancer diagnostics and genomic profiling through the power of gene expression | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celtic Pharma Management LP
Celtic Pharma Management LP Investment ManagersFinance Celtic Pharma invests in life sciences companies located in Bermuda. The firm targets companies operating in the fields of biotechnology, pharmaceuticals and biological drugs. It provides financing for later stage companies and also takes controlling interest. | Finance |
Gilda's Club New York City, Inc.
Gilda's Club New York City, Inc. Miscellaneous Commercial ServicesCommercial Services Provides support services to cancer patients | Commercial Services |
Stanford Graduate School of Business
 Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Werewolf Therapeutics, Inc.
 Werewolf Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer | Health Technology |
Intrepida Bio, Inc.
Intrepida Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines that modulates innate immune system to fight cancer | Health Technology |
Field Trip Health Ltd.
 Field Trip Health Ltd. Medical/Nursing ServicesHealth Services Provides psychedelic-enhanced psychotherapy services | Health Services |
Reunion Neuroscience, Inc.
Reunion Neuroscience, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops FDA-approved serotonergic psychedelic therapeutic solutions for underserved mental health disorders | Health Technology |
